Purpose and Approach:
To report a case of morphea (localized scleroderma) in a patient following breast cancer therapy and to summarize the current literature.
Results and Conclusion:
The occurrence of morphea is an unexpected late effect (approximately 1 year after the end of radiation therapy) which occurs frequently in the irradiated breast in women with breast-conserving therapy. The pathogenesis is unclear. The main differential diagnoses are recurrence of carcinoma and a radiogenic subcutaneous fibrosis (in most cases, the final diagnosis can only be made by means of a biopsy). Diagnosis and therapy must be performed in cooperation between dermatologist and radiooncologist.
Ziel und Vorgehen:
Die Autoren berichten über eine Patientin mit lokalisierter Sklerodermie (Morphaea) nach brusterhaltender Therapie und Bestrahlung und geben einen Überblick über die aktuelle Literatur.
Ergebnisse und Schlussfolgerung:
Das Auftreten einer Morphaea ist ein unerwarteter Späteffekt (etwa 1 Jahr nach dem Ende der Strahlentherapie), welcher häufiger in der bestrahlten Brust bei Frauen nach brusterhaltender Therapie auftritt. Die Pathogenese ist unklar. Die wichtigsten Differentialdignosen sind ein lokales Rezidiv und eine radiogene subkutane Fibrose (in den meisten Fällen kann die endgültige Diagnose nur bioptisch gestellt werden). Diagnose und Therapie müssen in Kooperation zwischen Dermatologen und Radioonkologen erfolgen.
Similar content being viewed by others
References
Abu-Shakra M, Guillemin F, Lee P. Cancer in systemic sclerosis. Arthritis Rheum 1993;36:460–4.
Andreassen CN. Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles? Acta Oncol 2005;44:801–15.
Ardern-Jones MR, Black MM. Widespread morphoea following radiotherapy for carcinoma of the breast. Clin Exp Dermatol 2003;28:160–2.
Bleasel NR, Stapleton KM, Commens C, et al. Radiation-induced localized scleroderma in breast cancer patients. Australas J Dermatol 1999;40:99–102.
Chen AM, Obedian E, Haffty BG. Breast-conserving therapy in the setting of collagen vascular disease. Cancer J 2001;7:480–91.
Clarke D, Martinez A, Cox RS. Analysis of cosmetic results and complications in patients with stage I and II breast cancer treated by biopsy and irradiation. Int J Radiat Oncol Biol Phys 1983;9:1807–13.
Colver GB, Rodger A, Mortimer PS, et al. Post-irradiation morphoea. Br J Dermatol 1989;120:831–5.
Cooper SG, Denham JW. Progressive systemic sclerosis (diffuse scleroderma) and radiotherapy. Br J Radiol 1990;63:804–5.
Crocker HR. Circumschribed scleroderma. In: Crocker HR. Diseases of the Skin. London: Lewis, 1893:375–83.
Dancey AL, Waters RA. Morphea of the breast. Two case reports and discussion of the literature. J Plast Reconstr Aesthet Surg 2006;59:1114–7.
Davis DA, Cohen PR, McNeese MD, et al. Localized scleroderma in breast cancer patients treated with supervoltage external beam radiation: radiation port scleroderma. J Am Acad Dermatol 1996;35:923–7.
Dubner S, Bovi J, White J, et al. Postirradiation morphea in a breast cancer patient. Breast J 2006;12:173–6.
Fischer M, Bormann G, Wohlrab J, et al. [Radiation-induced morphea.] Hautarzt 1999;50:507–10.
Forbes AM, Woodrow JC, Verbov JL, et al. Carcinoma of breast and scleroderma: four further cases and a literature review. Br J Rheumatol 1989;28:65–9.
Gollob MH, Dekoven JG, Bell MJ, et al. Postradiation morphea. J Rheumatol 1998;25:2267–9.
Hoeller U, Borgmann K, Feyer P, et al. Zur Interaktion von Strahlentherapie und Tamoxifen beim Mammakarzinom. Strahlenther Onkol 2007;183:535–44.
Hölscher T, Bentzen SM, Baumann M. Influence of connective tissue diseases on the expression of radiation side effects: a systematic review. Radiother Oncol 2006;78:123–30.
Lin A, Abu-Isa E, Griffith KA, et al. Toxicity of radiotherapy in patients with collagen vascular disease. Cancer 2008;113:648–53.
Mayr NA, Rigges CE Jr, Saag KG, et al. Mixed connective tissue disease and radiation toxicity. A case report. Cancer 1997;79:612–8.
Morris MM, Powell SN. Irradiation in the setting of collagen vascular disease: acute and late complications. J Clin Oncol 1997;15:2728–35.
Pinn ME, Gold DG, Petersen IA, et al. Systemic lupus erythematosus, radiotherapy, and the risk of acute and chronic toxicity: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys 2008;71:498–506.
Ransom DT, Cameron FG. Scleroderma - a possible contraindication to lumpectomy and radiotherapy in breast carcinoma. Australas Radiol 1987;31:317–8.
Reddy SM, Pui JC, Gold LI, et al. Postirradiation morphea and subcutaneous polyarteritis nodosa: case report and literature review. Semin Arthritis Rheum 2005;34:728–34.
Riekki R, Jukkola A, Sassi ML, et al. Modulation of skin collagen metabolism by irradiation: collagen synthesis is increased in irradiated human skin. Br J Dermatol 2000;142:874–80.
Robertson JM, Clarke DH, Pevzner MM, et al. Breast conservation therapy. Severe breast fibrosis after radiation therapy in patients with collagen vascular disease. Cancer 1991;68:502–8.
Ross JG, Hussey DH, Mayr NA, et al. Acute and late reactions to radiation therapy in patients with collagen vascular diseases. Cancer 1993;71:3744–52.
Sautter-Bihl ML, Budach W, Dunst J, et al. DEGRO practical guidelines for radiotherapy of breast cancer I. Breast-conserving therapy. Strahlenther Onkol 2007;183:661–6.
Sautter-Bihl ML, Souchon R, Budach W, et al. DEGRO practical guidelines for radiotherapy of breast cancer II. Postmastectomy radiotherapy, irradiation of regional lymphatics, and treatment of locally advanced disease. Strahlenther Onkol 2008;184:347–53.
Schaffer JV, Carroll C, Dvoretsky I, et al. Postirradiation morphea of the breast presentation of two cases and review of the literature. Dermatology 2000;200:67–71.
Seale M, Koh W, Henderson M, et al. Imaging surveillance of the breast in a patient diagnosed with scleroderma after breast-conserving surgery and radiotherapy. Breast J 2008;14:379–81.
Shetty G, Lewis F, Thrush S. Morphea of the breast: case reports and review of literature. Breast J 2007;13:302–4.
Smith KJ, Yeager J, Skelton HG. Localized scleroderma in breast cancer patients treated with supervoltage external beam radiation: radiation port scleroderma. J Am Acad Dermatol 1997;37:806–8.
Strasser H, Grabenbauer GG, Sprung CN, et al. DNA double-strand break induction and repair in irradiated lymphoblastoid, fibroblast cell lines and white blood cells from ATM, NBS and radiosensitive patients. Strahlenther Onkol 2007;183:447–53.
Tang Y, Zhang Y, Guo L, et al. Relationship between individual radiosen-sitivity and radiation encephalopathy of nasopharyngeal carcinoma after radiotherapy. Strahlenther Onkol 2008;184:510–4.
Trattner A, Figer A, David M, et al. Circumscribed scleroderma induced by postlumpectomy radiation therapy. Cancer 1991;68:2131–3.
Ullén H, Björkholm E. Localized scleroderma in a woman irradiated at two sites for endometrial and breast carcinoma:a case history and a review of the literature. Int J Gynecol Cancer 2003;13:77–82.
Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007;117:557–67.
Walsh N, Rheaume D, Barnes P, et al. Postirradiation morphea: an underrecognized complication of treatment for breast cancer. Hum Pathol 2008;39:1680–8.
Winkelmann RK, Grado GL, Quimby SR, et al. Pseudosclerodermatous panniculitis after irradiation: an unusual complication of megavoltage treatment of breast carcinoma. Mayo Clin Proc 1993;68:122–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Herrmann, T., Günther, C. & Csere, P. Localized Morphea – a Rare but Significant Secondary Complication Following Breast Cancer Radiotherapy. Strahlenther Onkol 185, 603–607 (2009). https://doi.org/10.1007/s00066-009-2051-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-009-2051-3